Open AccessFluoroquinolone Susceptibility among Mycobacterium tuberculosis Isolates from the United States and Canada
Author(s) -
Lorna Bozeman,
W. J. Burman,
Beverly Metchock,
Lindsay Welch,
Marc Weiner
Publication year - 2005
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/427292
Subject(s) - isoniazid , medicine , ciprofloxacin , tuberculosis , rifampicin , mycobacterium tuberculosis , antibiotics , antibacterial agent , drug resistance , microbiology and biotechnology , biology , pathology
There is increasing interest in the possible role of new fluoroquinolone antibiotics for treatment of tuberculosis, but widespread use of fluoroquinolones for treatment of other bacterial infections may select for resistant strains of Mycobacterium tuberculosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom